Quaker BioVentures II LP - 02 Jun 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
10%+ Owner
Signature
Quaker BioVentures II, L.P. By: Quaker BioVentures Capital II, L.P., its general partner By Quaker BioVentures Capital II, LLC, its general partner By: /s/ Adele C. Oliva, Executive Manager
Issuer symbol
TELA
Transactions as of
02 Jun 2022
Net transactions value
$0
Form type
4
Filing time
23 Jun 2022, 06:30:46 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Other $0 -1,751,100 -100% $0.000000* 0 02 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Quaker BioVentures II LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Quaker BioVentures II, L.P. distributed these shares on a pro rata basis, for no consideration.
F2 Quaker BioVentures Capital II, L.P., the general partner of Quaker BioVentures II, L.P., received its pro rata shares in the distribution and in turn distributed all such shares to its own partners.